Organon & Co | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Bristol-Myers Squibb USD 485M 9M 2025-06
Celltrion KRW 17.04B 1.34B 2025-03
Cspc Pharmaceutical 10.38M 934K 2024-12
Dianthus Therapeutics 4.44M 263K 2024-09
Divis Laboratories Ltd 30M 20M 2025-06
Gilead Sciences USD 254M 6M 2025-06
Glaxosmithkline 178.05M 24.73M 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Merck USD 305M 8M 2025-06
Neuren Pharmaceuticals 0 0 2024-06
Novartis USD 275M 11M 2024-12
Organon & Co USD 131M 7M 2025-06
Qiagen NV USD 7.6M 311K 2025-06
Sartorius 41.4M 51.4M 2025-06
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 7.77M 2.08M 2024-11


Organon & Co Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.